Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid plus paclitaxel for anaplastic thyroid cancer
2008-005221-11Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of valproic acid and paclitaxel in anaplastic thyroid cancer (ATC), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Overall survival and Tumor response by WHO criteria. Started Sep 2008; status: active.
02
Drugs
valproic acidpaclitaxel
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on 2008-005221-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005221-11.